Oxidative stress is a central mechanism that links metabolic health, immune function, inflammation, and hormonal signaling. Although often discussed as a biochemical concept, oxidative stress represents a dynamic physiologic state that influences nearly every organ system. For clinicians working in integrative and women’s health, understanding how oxidative stress interacts with immune pathways and hormonal changes across the lifespan is essential for both prevention and treatment.

Understanding Oxidative Stress

Reactive oxygen species (ROS) are typically balanced in the body by antioxidants. Oxidative stress mainly occurs when the production of ROS exceeds the body’s ability to mount appropriate antioxidant defenses. ROS are generated through normal physiologic functions like cell energy production, immune activation, and cellular metabolism. They serve as signaling molecules that regulate cell growth, apoptosis (cell death and recycling), and immunity. However, when ROS accumulate beyond the capacity of antioxidant systems such as glutathione, catalase, and superoxide dismutase, they begin to damage cellular structures.

Oxidative stress has a dual role: it is essential for normal signaling but can be harmful when it becomes dysregulated.¹ Excess ROS can damage DNA, oxidize lipids, impair protein function, and disrupt mitochondrial integrity. Over time, this contributes to aging, neurodegeneration, cardiovascular disease, and metabolic dysfunction. Even under typical conditions, inadequate antioxidant capacity can lead to oxidative stress, but sometimes ROS production is increased, leading to worse outcomes. Common triggers of increased ROS production include: environmental exposures, poor diet, chronic psychological stress, sedentary behavior, and hormonal changes.

Antioxidant Response and Cellular Injury

The body’s antioxidant response is designed to neutralize ROS and repair oxidative damage but when this system becomes overwhelmed, oxidative stress leads to structural and functional injury. DNA strand breaks impair replication and increase mutational burden. Lipid peroxidation compromises membrane integrity and cellular signaling. Protein oxidation alters enzyme function and accelerates cellular aging. Mitochondrial injury reduces ATP production and further amplifies ROS generation, creating a self-perpetuating cycle. Clinically, poor mitochondrial function may present as fatigue, brain fog, reduced exercise tolerance, weight changes, and increased sensitivity to stress or illness—symptoms commonly seen in chronic inflammatory and hormonal conditions.

Oxidative Stress and the Immune System

The immune system relies on controlled ROS production as part of its defense strategy. Neutrophils and macrophages generate ROS during the respiratory burst to kill pathogens, and ROS modulate cytokine production and influence T-cell and B-cell differentiation. T‑cells and B‑cells are the primary cells of the adaptive immune system and play central roles in immune memory, autoimmunity, inflammation, and hormone‑immune interactions. However, excessive ROS can disrupt immune homeostasis. Over time, chronic oxidative stress amplifies inflammatory cytokine production and impairs immune tolerance, which in turn alters innate and adaptive immune responses. Sex hormones and epigenetic mechanisms shape innate immunity, with oxidative stress acting as a mediator of these differences. Specifically, testosterone provides a protective role against autoimmunity, and men with autoimmune diseases have been shown to have higher circulating estradiol levels than unaffected males.²

Inflammation and Oxidative Stress

Inflammation and oxidative stress are tightly linked. ROS activate inflammatory transcription factors such as NF‑κB. NF‑κB (nuclear factor kappa‑B) is a master inflammatory “switch” inside cells. It is a transcription factor, meaning it turns genes on and off. When the body is exposed to stress, such as infection, injury, oxidative stress, or hormonal changes, NF‑κB becomes activated and enters the cell nucleus, where it signals the cell to produce inflammatory molecules.

Among the molecules NF‑κB activates are cytokines, which are chemical messengers the immune system uses to communicate. The most important cytokines in this pathway include: 

• IL‑1β (Interleukin‑1 beta): A powerful early inflammatory signal that promotes fever, pain sensitivity, and immune cell activation. It plays a major role in autoimmune disease, joint inflammation, and chronic pain states.
• IL‑6 (Interleukin‑6): A cytokine involved in both acute inflammation and long‑term, low‑grade inflammation. IL‑6 influences metabolism, insulin sensitivity, fatigue, and mood, and is commonly elevated in chronic inflammatory and cardiometabolic conditions.
• TNF‑α (Tumor Necrosis Factor alpha): A central driver of systemic inflammation that promotes immune activation, tissue damage, and insulin resistance. Excess TNF‑α is strongly linked to autoimmune disease, inflammatory bowel disease, and chronic inflammatory states.

When NF‑κB remains chronically activated, as can occur with persistent oxidative stress, psychological stress, metabolic dysfunction, or declining estrogen, it drives ongoing production of these cytokines, creating a self‑perpetuating cycle of inflammation and cellular damage. This bidirectional relationship is a core mechanism underlying metabolic syndrome, obesity‑related inflammation, and other chronic diseases.³ Once established, this cycle can persist for years, driving tissue damage and accelerating biological aging.

Hormones as Modulators of Immunity, Inflammation, and Oxidative Stress

Sex hormones exert profound effects on immune regulation and oxidative balance. Estrogen enhances antibody production, modulates T‑cell differentiation, suppresses pro‑inflammatory cytokines, and upregulates antioxidant enzyme expression. Progesterone promotes immune tolerance and dampens inflammatory signaling. Testosterone is generally immunosuppressive, reducing inflammatory cytokine production while also lowering immune vigilance.

Hormones also directly influence oxidative stress. Estrogen has antioxidant properties that protect against lipid peroxidation and support mitochondrial efficiency. As estrogen declines during perimenopause and menopause, oxidative stress increases, contributing to cardiometabolic risk, neurodegenerative vulnerability, and accelerated aging.

In 2025, Kim et al. published an analysis from the Health and Retirement Study examining early menopause, hysterectomy, and biological aging. Hysterectomy at any age was associated with accelerated biological aging, likely reflecting reduced ovarian hormone production, including both estrogen and testosterone. Natural early menopause was also associated with accelerated epigenetic aging even in the absence of hysterectomy. These findings suggest that reduced lifetime exposure to estrogen and testosterone (whether due to ovarian removal, impaired ovarian perfusion following hysterectomy, or early ovarian senescence) is associated with advanced cellular and systemic aging.⁴

The Menstrual Cycle and Immune Function

Immune activity even fluctuates across the menstrual cycle. Rising estrogen in the follicular phase supports immune activation, while progesterone in the luteal phase shifts the immune system toward tolerance. These cyclical changes influence susceptibility to infection, autoimmune flares, and inflammatory symptoms.

Hormones and B-cell development research demonstrates that hormone signaling, together with immune derived signals, regulates multiple mechanisms in B-cells. The endocrine immune network is complex and cannot be viewed in isolation. Because B-cells play a major role in autoimmune disease onset, hormonal effects on B-cell function may explain the sexual dimorphism seen in autoimmune disorders. Some hormonal abnormalities (particularly involving estrogen, prolactin, and possibly growth hormone) may exacerbate autoimmune disease, while testosterone and progesterone may have protective effects.⁵

Menopause and Immune Changes

Menopause represents a major shift in immune and inflammatory balance. Declining estrogen increases pro‑inflammatory cytokine production, reduces antioxidant capacity, and alters T‑cell and B‑cell function. Hormone therapy can partially restore immune regulation. Women in early and mid‑postmenopause demonstrate elevated IFN‑γ (a pro‑inflammatory cytokine that drives cell‑mediated immune activation) levels, while later postmenopause is characterized by rising IL‑10 and a type‑2 dominant cytokine profile. Hormone therapy lowers IFN‑γ in early and mid‑postmenopause and reduces IL‑10 in later stages, highlighting its immunomodulatory effects.⁶

Emerging evidence from the COVID‑19 pandemic suggests menopausal hormone therapy (MHT) may influence immune responses to viral infection. Physiologic estrogen and progesterone levels reduce pro‑inflammatory cytokines, promote regulatory T‑cell responses, and enhance antibody production. Current evidence suggests MHT should not be discontinued during COVID‑19 infection except in cases of critical illness.⁷

Hormone Therapy and the Transition Phase

Though often touted as a panacea for all ills, initiating hormone therapy is not physiologically neutral. After prolonged estrogen deficiency, reintroducing estrogen requires metabolic and immune recalibration. Early hormone therapy can temporarily heighten inflammatory signaling or increase reactive oxygen species because previously quiescent estrogen responsive pathways become reactivated, hepatic metabolism shifts—especially with oral estrogen, which increases liver derived inflammatory proteins—and the immune system undergoes recalibration as T-cell and B-cell networks adjust to new hormonal inputs. These effects are further shaped by the timing hypothesis, in which earlier initiation of therapy aligns more favorably with vascular and immune physiology, whereas later initiation may produce more variable responses including increased risk for cardiovascular disease, stroke and DVT. During this adjustment window, ROS also functions as adaptive signaling molecules as mitochondria modify their respiratory activity and receptor sensitivity, creating a short-term rise in oxidative activity before stabilizing into a more balanced state.

These transitional effects do not negate long-term benefits but highlight the importance of route, dose, timing, and individualized risk assessment. Transdermal estradiol generally produces fewer inflammatory shifts than oral formulations, and micronized progesterone is typically more immunomodulatory than synthetic progestins as well as less prothrombotic and more breast friendly.

Strategies to Reduce Oxidative Stress

Reducing oxidative stress requires a multifaceted approach with diet playing a central role. The traditional Mediterranean diet incorporates minimally processed, fiber-rich plant foods packed with vitamins, minerals, and phytochemicals. Moderate energy restriction, low intake of sulfur containing and branched chain amino acids, and the microbiome’s processing of diverse plant foods contribute to its prolongevity effects. However, more research is needed to understand how calorie intake, nutrient composition, microbiome diversity, and physical activity interact to promote cellular and systemic health. ⁸

Supplements such as vitamin C, vitamin E, N‑acetylcysteine, alpha‑lipoic acid, CoQ10, and polyphenols can support antioxidant defenses when clinically appropriate. Hormone therapy may reduce inflammatory cytokines, improve mitochondrial function, and enhance antioxidant capacity in eligible patients.

Lifestyle interventions like regular exercise, stress reduction, sleep optimization, and minimizing environmental toxin exposure can further reduce oxidative load. Exercise improves mitochondrial efficiency and upregulates endogenous antioxidant systems, creating long-term resilience against oxidative injury.

Conclusion

Oxidative stress sits at the crossroads of metabolism, immunity, inflammation, and hormonal regulation. Its influence spans the menstrual cycle, reproductive transitions, and aging. Understanding how ROS, immune pathways, and sex hormones interact allows clinicians to better anticipate symptom patterns, personalize hormone therapy, and implement targeted lifestyle and nutritional strategies. By integrating dietary interventions, stress management, exercise, and hormone therapy (when appropriate), practitioners can help patients restore physiologic balance, reduce inflammatory burden, and support healthier aging across the lifespan.

Resources

1. Liu S, Liu J, Wang Y, Deng F, Deng Z. Oxidative Stress: Signaling Pathways, Biological Functions, and Disease. MedComm (2020). 2025;6(7):e70268. Published 2025 Jul 1. doi:10.1002/mco2.70268
2. Shepherd R, Cheung AS, Pang K, Saffery R, Novakovic B. Sexual Dimorphism in Innate Immunity: The Role of Sex Hormones and Epigenetics. Front Immunol. 2021;11:604000. Published 2021 Jan 21. doi:10.3389/fimmu.2020.604000
3. Hotamisligil GS. Inflammation, metaflammation and immunometabolic disorders. Nature. 2017;542(7640):177-185. doi:10.1038/nature21363
4. Kim, Jung Ki PhD; Crimmins, Eileen M. PhD. Early menopause, hysterectomy, and biological aging: Health and Retirement Study. Menopause 32(8):p 692-701, August 2025. | DOI: 10.1097/GME.0000000000002555
5. Santana-Sánchez P, Vaquero-García R, Legorreta-Haquet MV, Chávez-Sánchez L, Chávez-Rueda AK. Hormones and B-cell development in health and autoimmunity. Front Immunol. 2024;15:1385501. Published 2024 Apr 12. doi:10.3389/fimmu.2024.1385501
6. Deguchi, Keizo MD1; Kamada, Masaharu MD, PhD1; Irahara, Minoru MD, PhD1; Maegawa, Masahiko MD, PhD1; Yamamoto, Satoshi MD, PhD1; Ohmoto, Yasukazu PhD2; Murata, Kaoru2; Yasui, Toshiyuki MD, PhD1; Yamano, Shuji MD, PhD1; Aono, Toshihiro MD, PhD1. Postmenopausal changes in production of type 1 and type 2 cytokines and the effects of hormone replacement therapy. Menopause 8(4):p 266-273, July 2001.
7. Averyanova M, Vishnyakova P, Yureneva S, et al. Sex hormones and immune system: Menopausal hormone therapy in the context of COVID-19 pandemic. Front Immunol. 2022;13:928171. Published 2022 Aug 2. doi:10.3389/fimmu.2022.928171
8. Tosti V, Bertozzi B, Fontana L. Health Benefits of the Mediterranean Diet: Metabolic and Molecular Mechanisms. J Gerontol A Biol Sci Med Sci. 2018;73(3):318-326. doi:10.1093/gerona/glx227